ATH 25.0% 0.3¢ alterity therapeutics limited

congratulations prana, page-6

  1. 64 Posts.
    Simple Question:

    If we show the same cognitive improvements ( or possibly better with different dosages in later trials) for the AD results, would there be the same negative reaction?? In my opinion: no.

    AD was always the bigger market and the main focus.

    I look forward to the AD results to hopefully put an end all of this conjecture.

    Good luck to all holders

    This is not financial advice.DYOR
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.